BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19278964)

  • 1. Caspase-independent type III programmed cell death in chronic lymphocytic leukemia: the key role of the F-actin cytoskeleton.
    Barbier S; Chatre L; Bras M; Sancho P; Roué G; Virely C; Yuste VJ; Baudet S; Rubio M; Esquerda JE; Sarfati M; Merle-Béral H; Susin SA
    Haematologica; 2009 Apr; 94(4):507-17. PubMed ID: 19278964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of CD47-induced caspase-independent cell death in normal and leukemic cells: link between phosphatidylserine exposure and cytoskeleton organization.
    Mateo V; Brown EJ; Biron G; Rubio M; Fischer A; Deist FL; Sarfati M
    Blood; 2002 Oct; 100(8):2882-90. PubMed ID: 12351399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia.
    Mateo V; Lagneaux L; Bron D; Biron G; Armant M; Delespesse G; Sarfati M
    Nat Med; 1999 Nov; 5(11):1277-84. PubMed ID: 10545994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD47 agonist peptides induce programmed cell death in refractory chronic lymphocytic leukemia B cells via PLCγ1 activation: evidence from mice and humans.
    Martinez-Torres AC; Quiney C; Attout T; Boullet H; Herbi L; Vela L; Barbier S; Chateau D; Chapiro E; Nguyen-Khac F; Davi F; Le Garff-Tavernier M; Moumné R; Sarfati M; Karoyan P; Merle-Béral H; Launay P; Susin SA
    PLoS Med; 2015 Mar; 12(3):e1001796. PubMed ID: 25734483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drp1 mediates caspase-independent type III cell death in normal and leukemic cells.
    Bras M; Yuste VJ; Roué G; Barbier S; Sancho P; Virely C; Rubio M; Baudet S; Esquerda JE; Merle-Béral H; Sarfati M; Susin SA
    Mol Cell Biol; 2007 Oct; 27(20):7073-88. PubMed ID: 17682056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of caspase-dependent programmed cell death in B-cell chronic lymphocytic leukemia by anti-CD22 immunotoxins.
    Decker T; Oelsner M; Kreitman RJ; Salvatore G; Wang QC; Pastan I; Peschel C; Licht T
    Blood; 2004 Apr; 103(7):2718-26. PubMed ID: 14525789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia.
    Kashyap MK; Amaya-Chanaga CI; Kumar D; Simmons B; Huser N; Gu Y; Hallin M; Lindquist K; Yafawi R; Choi MY; Amine AA; Rassenti LZ; Zhang C; Liu SH; Smeal T; Fantin VR; Kipps TJ; Pernasetti F; Castro JE
    J Hematol Oncol; 2017 May; 10(1):112. PubMed ID: 28526063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic Resistance of Chronic Lymphocytic Leukemia Cells to NK Cell-Mediated Lysis Can Be Overcome
    Wurzer H; Filali L; Hoffmann C; Krecke M; Biolato AM; Mastio J; De Wilde S; François JH; Largeot A; Berchem G; Paggetti J; Moussay E; Thomas C
    Front Immunol; 2021; 12():619069. PubMed ID: 34108958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of NOXA and its ubiquitination in proteasome inhibitor-induced apoptosis in chronic lymphocytic leukemia cells.
    Baou M; Kohlhaas SL; Butterworth M; Vogler M; Dinsdale D; Walewska R; Majid A; Eldering E; Dyer MJ; Cohen GM
    Haematologica; 2010 Sep; 95(9):1510-8. PubMed ID: 20378569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia.
    Chu P; Deforce D; Pedersen IM; Kim Y; Kitada S; Reed JC; Kipps TJ
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3854-9. PubMed ID: 11891278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Farnesyltransferase inhibitor BMS-214662 induces apoptosis in B-cell chronic lymphocytic leukemia cells.
    Marzo I; Pérez-Galán P; Giraldo P; López-Royuela N; Gómez-Benito M; Larrad L; Lasierra P; Rubio-Félix D; Anel A; Naval J
    Leukemia; 2004 Oct; 18(10):1599-604. PubMed ID: 15356656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses.
    Kitada S; Andersen J; Akar S; Zapata JM; Takayama S; Krajewski S; Wang HG; Zhang X; Bullrich F; Croce CM; Rai K; Hines J; Reed JC
    Blood; 1998 May; 91(9):3379-89. PubMed ID: 9558396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-2 regulatory pathway is functional in chronic lymphocytic leukemia.
    Goolsby C; Paniagua M; Tallman M; Gartenhaus RB
    Cytometry B Clin Cytom; 2005 Jan; 63(1):36-46. PubMed ID: 15624202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caspase-independent type III PCD: a new means to modulate cell death in chronic lymphocytic leukemia.
    Merle-Béral H; Barbier S; Roué G; Bras M; Sarfati M; Susin SA
    Leukemia; 2009 May; 23(5):974-7. PubMed ID: 19005478
    [No Abstract]   [Full Text] [Related]  

  • 15. Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia.
    Fiorcari S; Martinelli S; Bulgarelli J; Audrito V; Zucchini P; Colaci E; Potenza L; Narni F; Luppi M; Deaglio S; Marasca R; Maffei R
    Haematologica; 2015 Feb; 100(2):253-62. PubMed ID: 25398834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiation.
    Jones DT; Ganeshaguru K; Virchis AE; Folarin NI; Lowdell MW; Mehta AB; Prentice HG; Hoffbrand AV; Wickremasinghe RG
    Blood; 2001 Nov; 98(9):2800-7. PubMed ID: 11675354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced apoptosis in chronic lymphocytic leukemia.
    Stoetzer OJ; Pogrebniak A; Scholz M; Pelka-Fleischer R; Gullis E; Darsow M; Nüssler V; Wilmanns W
    Leukemia; 1999 Nov; 13(11):1873-80. PubMed ID: 10557065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-alpha-mediated prevention of in vitro apoptosis of chronic lymphocytic leukemia B cells: role of bcl-2 and c-myc.
    Chaouchi N; Wallon C; Taieb J; Auffredou MT; Tertian G; Lemoine FM; Delfraissy JF; Vazquez A
    Clin Immunol Immunopathol; 1994 Nov; 73(2):197-204. PubMed ID: 7923926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous and drug-induced apoptosis is mediated by conformational changes of Bax and Bak in B-cell chronic lymphocytic leukemia.
    Bellosillo B; Villamor N; López-Guillermo A; Marcé S; Bosch F; Campo E; Montserrat E; Colomer D
    Blood; 2002 Sep; 100(5):1810-6. PubMed ID: 12176904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
    de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
    Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.